Heparin-Binding Protein: A Prognostic Biomarker Associated with Severe or Complicated Community-Acquired Pneumonia in

Shuang Li1,2, Yanwen Xu2, Yuhang Wu2

  • 1Department of Infectious Diseases, The Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, Zhejiang, People's Republic of China.

Insights

Elevated serum heparin-binding protein (HBP) in children with community-acquired pneumonia (CAP) indicates a higher risk of severe disease and poor prognosis. This finding suggests HBP may be a valuable biomarker for assessing CAP severity.

Area of Science:

  • Pediatric Infectious Diseases
  • Biomarker Discovery
  • Inflammatory Disease Research

Background:

  • Heparin-binding protein (HBP) is recognized as a novel biomarker for various inflammatory conditions.
  • Community-acquired pneumonia (CAP) in children presents a significant health challenge, necessitating improved diagnostic and prognostic tools.

Purpose of the Study:

  • To investigate the role of serum HBP in pediatric CAP.
  • To assess the association between HBP levels and CAP severity and prognosis.

Main Methods:

  • Retrospective analysis of 125 children hospitalized with CAP.
  • Correlation analysis of HBP levels with clinical characteristics and inflammatory markers.
  • Receiver operator characteristic (ROC) curve analysis and multivariate logistic regression to evaluate HBP's predictive performance.

Main Results:

  • Children with upper-quartile HBP concentrations (≥60 ng/mL) had a significantly higher rate of severe or complicated CAP (54.8% vs. 26.6%).
  • HBP levels correlated with neutrophil counts, CRP, ESR, and serum amyloid A.
  • Higher HBP concentration was associated with a three-fold increased risk of severe/complicated CAP (aOR=3.11).
  • A predictive model including HBP demonstrated an AUC of 0.75 for severe CAP.

Conclusions:

  • Elevated serum HBP is significantly associated with severe or complicated CAP and poorer outcomes in children.
  • HBP shows potential as a valuable biomarker for predicting CAP severity in pediatric patients.
  • Further research into HBP's role in CAP pathogenesis is warranted.
Abstract

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
333
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
134
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
819
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
22
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
298
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
412